INVO Fertility (IVF) Enterprise Value Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.09% |
| Jun 30, 2025 | 19.77% |
| Mar 31, 2025 | -19.15% |
| Dec 31, 2024 | 9.75% |
| Sep 30, 2024 | 24.29% |
| Jun 30, 2024 | 19.51% |
| Mar 31, 2024 | 31.09% |
| Dec 31, 2023 | -1.83% |
| Sep 30, 2023 | -13.76% |
| Jun 30, 2023 | 31.02% |
| Mar 31, 2023 | -128.14% |
| Dec 31, 2022 | -28.47% |
| Sep 30, 2022 | -51.96% |
| Jun 30, 2022 | -155.35% |
| Mar 31, 2022 | -149.58% |
| Dec 31, 2021 | -106.23% |
| Sep 30, 2021 | -80.48% |
| Jun 30, 2021 | -83.01% |
| Mar 31, 2021 | -81.87% |
| Dec 31, 2020 | -83.00% |
| Sep 30, 2020 | -51.30% |
| Jun 30, 2020 | -79.99% |
| Mar 31, 2020 | -70.25% |
| Dec 31, 2019 | -131.51% |
| Sep 30, 2019 | -217.04% |
| Jun 30, 2019 | -214.66% |
| Mar 31, 2019 | -234.91% |
| Dec 31, 2018 | -63.75% |
| Sep 30, 2018 | -136.41% |
| Jun 30, 2018 | -216.30% |
| Mar 31, 2018 | -120.00% |
| Dec 31, 2017 | -29.06% |
| Sep 30, 2017 | -4.95% |
| Jun 30, 2017 | 10.49% |
| Mar 31, 2017 | -113.83% |
| Dec 31, 2016 | -227.75% |
| Sep 30, 2016 | -158.51% |
| Jun 30, 2016 | -101.66% |
| Dec 31, 2015 | -108.37% |